Recon: FDA approves Merck’s pneumococcal jab; Boston Scientific to purchase Silk Road Medical for $1.16B
ReconJason Scott
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States